U.S. Markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed Price. Currency in USD
152.65+1.52 (+1.01%)
At close: 04:00PM EDT
152.35 -0.30 (-0.20%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close151.13
Bid152.30 x 1000
Ask152.90 x 800
Day's Range150.83 - 152.76
52 Week Range150.11 - 186.69
Avg. Volume8,039,859
Market Cap399.1B
Beta (5Y Monthly)0.54
PE Ratio (TTM)26.97
EPS (TTM)5.66
Earnings DateApr 18, 2023
Forward Dividend & Yield4.52 (2.80%)
Ex-Dividend DateFeb 17, 2023
1y Target Est183.63
  • Investopedia

    Who Are Pfizer's (PFE) Main Competitors?

    Pfizer's biggest competitors in the global pharmaceutical industry are Johnson & Johnson, Roche, Eli Lilly, AbbVie, Novo Nordisk, and Merck.

  • Motley Fool

    Better Buy: AbbVie vs. Johnson & Johnson

    AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) did something many other stocks didn't last year. After all, these stocks offer a track record of earnings growth and dividend increases. The company's mega-blockbuster immunology drug, Humira, recently started facing competition in the U.S. And AbbVie predicts that this will result in a 37% decline in the drug's sales this year.

  • Yahoo Finance

    What young TikTok creators think about a possible ban: 'People will freak out'

    It’s not just TikTok as a company that has a lot at stake right now. The people who are on TikTok the most, the influencers — also called creators — are also in the crosshairs.